Established in 1999 in Shenzhen, China, LifeTech Scientific Corporation (Stock Code: 1302.HK) is committed to the R&D, manufacture, and sales of minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases. The Company provides patients with innovative solutions in the treatment of structural heart diseases, peripheral vascular diseases, and bradycardia, and the Company also expands its business scope in respiratory interventional business and neuro interventional business. Moreover, the Company has the world-first innovative iron-based bioabsorbable material technology platform. With the core strategy of innovation and internationalization, the market share of main products of the Company are keeping leading position in the home country, and the Company has established 7 subsidiaries outside mainland China, with network penetration in nearly 120 countries and regions around the world.